Ability to swallow the study drug as a whole tablet
Participant is able to swallow a tablet whole
Able to swallow the study drug(s) whole as a tablet
Ability to swallow the study drug as a whole tablet.
Able to swallow the study drug whole as a tablet
Patient must be able to swallow capsule or tablet
Able to swallow the study drug whole as a tablet.
Able to swallow study drugs whole as a tablet/capsule.
Must be able to swallow ribociclib (LEE-) tablet/capsule
Patient must be able to swallow tablet or have existing gastrostomy feeding tube to enable administration of tablet
Be capable of swallowing study agents whole as a tablet
Able to swallow the study drugs whole as a tablet
Able to swallow study drugs whole as a tablet/capsule
Able to swallow the study drug as a whole tablet
Patient must be able to swallow capsule or tablet
Able to swallow the study drug whole as a tablet
Able to swallow the study drug whole as a tablet
Patients must have the ability to swallow the study drug whole as a tablet or capsule
Able to swallow the study drug whole as a tablet
Able to swallow the study drug whole as a tablet
Able to swallow the study drug whole as a tablet
Must demonstrate basic tablet skills, defined as the ability to open and close an application on the desktop of the tablet, and to be able to advance the screen by swiping left or right (required for the use of tNCF testing)
Unable to swallow a whole tablet or capsule.
Able to swallow the study drug whole as a tablet
Able to swallow the study drug whole as a tablet
Are willing and able to use a smartphone or tablet comfortably
Subjects that are unable to swallow a tablet/pill for any reason
Subjects that are unable to swallow a tablet/pill
